Harrow (HROW) Operating Expenses (2010 - 2026)
Harrow (HROW) posted Operating Expenses of $61.4 million for Q2 2026, up 24.93% on a QoQ basis from $49.1 million in Q1 2026, and up 69.99% year-over-year from $36.1 million in Q2 2025.
Analysis
Harrow (HROW) Operating Expenses (2010 - 2026) Analysis & Trends
Harrow has reported Operating Expenses for 17 years, with the latest figure at $61.4 million in Q2 2026.
- On a quarterly basis, Operating Expenses rose 69.99% year-over-year to $61.4 million in Q2 2026; TTM through Jun 2026 was $204.7 million, a 31.77% increase from a year earlier, with the FY2025 full-year figure at $173.9 million, up 22.82% from the prior year.
- Operating Expenses was $61.4 million for Q2 2026 at Harrow, up from $49.1 million in the prior quarter.
- The five-year high for Operating Expenses was $61.4 million in Q2 2026, with the low at $14.1 million in Q1 2022.
- Average Operating Expenses over 5 years is $32.1 million, with a median of $32.9 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses retreated 7.35% in 2022, then jumped 87.73% in 2023.
- Over 5 years, Operating Expenses stood at $15.9 million in 2022, then surged by 87.73% to $29.9 million in 2023, then surged by 32.98% to $39.8 million in 2024, then jumped by 38.28% to $55.0 million in 2025, then rose by 11.51% to $61.4 million in 2026.
- The last three Operating Expenses figures came in at $61.4 million (Q2 2026), $49.1 million (Q1 2026), and $55.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -5.98 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | 505.13 Mn |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 976.14 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 452.50 Mn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn | 61.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.37 Mn |
| Mar 31, 2026 | 49.13 Mn |
| Dec 31, 2025 | 55.03 Mn |
| Sep 30, 2025 | 39.18 Mn |
| Jun 30, 2025 | 36.10 Mn |
| Mar 31, 2025 | 43.54 Mn |
| Dec 31, 2024 | 39.80 Mn |
| Sep 30, 2024 | 35.92 Mn |
| Jun 30, 2024 | 34.87 Mn |
| Mar 31, 2024 | 30.96 Mn |
| Dec 31, 2023 | 29.93 Mn |
| Sep 30, 2023 | 22.45 Mn |
| Jun 30, 2023 | 21.12 Mn |
| Mar 31, 2023 | 16.62 Mn |
| Dec 31, 2022 | 15.94 Mn |
| Sep 30, 2022 | 16.20 Mn |
| Jun 30, 2022 | 15.10 Mn |
| Mar 31, 2022 | 14.06 Mn |
| Dec 31, 2021 | 16.86 Mn |
| Sep 30, 2021 | 17.48 Mn |